According to Talis Biomedical's latest financial reports the company has $59.86 Million USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $76.73 M | -41.06% |
2022-12-31 | $0.13 B | -44.01% |
2021-12-31 | $0.23 B | 67.92% |
2020-12-31 | $0.13 B | 541.01% |
2019-12-31 | $21.6 M | 213.33% |
2018-12-31 | $6.89 M |